References
- Alsalem, B. (2019). The diagnostic utility of cancer stem cell marker CD44 in early detection of oral cancer. Dissertation, Thesis Master of Science, University of Maryland, Baltimore. https://archive.hshsl.umaryland.edu/handle/10713/11708 (accessed 20.03.2021).
- Ambele, M. A,, van Zyl, A., Pepper, M. S., van Heerden, M. B., Heerden, W. F. P. (2020). Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33: Are possible common genetic alterations in oral cancer patients. Frontiers Oncol., 10, 1-8.10.3389/fonc.2020.00683720347932426287
- Alves, C. S., Yakovlev, S., Medved, L., Konstantopoulos, K. (2009). Bio-molecular characterization of CD44-fibrin(ogen) binding: Distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J. Biol Chem.,284 (2), 1177–1189.10.1074/jbc.M805144200261361019004834
- Anonymous (2020). GLOBOCAN, 2018. http://gco.iarc.fr (accessed 29.06.2020).
- Assimakopoulos, D., Kolettas, E., Patrikakos, G., Evangelou, A. (2002). The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol. Histopathol., 17 (4), 1269–1281.
- Boxberg, M., Götz, C., Haidari S., Dorfner, C., Jesinghaus, M., Drecoll, E., Boskov, M., Wolff, K. D., Weichert, W., Haller, B., Kolk, A. (2018). Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors. Histopathology, 73 (4), 559–572.10.1111/his.1349629468726
- Chen, D., Cun-YuWang, C.-Y (2019). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. Precision Clin. Med., 2 (3), 152–165.10.1093/pcmedi/pbz016677027731598386
- Diz, P., Meleti, M., Diniz-Freitas, M., Vescovi, P., Warnakulasuriya, S., Johnson, N. W., Kerr, A. K. (2017). Oral and pharyngeal cancer in Europe: Incidence, mortality and trends as presented to the Global Oral Cancer Forum. Transl. Res. Oral Oncol., 2, 1–310.1177/2057178X17701517
- Garcia, A. S., Assao, A., Carvalho, A. L., Soares F. A., Koalski L. P., Oliveira D. T. (2019). The stem cell markers expression CD44v6 and podoplanin in lip cancer: Clinical significance. Virchows Arch., 474 (6), 745–754.10.1007/s00428-019-02539-330770986
- Godge, P. Y., Poonja L. S. (2011). Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study. Indian J. Dent Res.,22 (3), 493–49410.4103/0970-9290.8708022048598
- Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., Shachar, I. (2008). Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem., 283 (5), 2784–2792.10.1074/jbc.M70326520018056708
- Groma, V., Kazanceva, A., Krukle, Z. N., Murovska, M. (2012). Oropharyngeal malignant epithelial cell, lymphocyte, and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: Immunohistochemical data and EBV DNA tissue indices. Pathol. Res. Practice,208 (9), 518–526.10.1016/j.prp.2012.05.01722770970
- Harada, H., Takahashi, M. (2007). CD44-dependeent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem., 282, 5597–5607.10.1074/jbc.M60835820017170110
- Herold-Mende, C., Seiter, S., Born, A. I., Patzelt, E., Schupp, M., Zölle, J., Bosch, F. X., Zöller, M. (1996). Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J. Pathol., 179 (1), 66–73.10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5
- Jakovlevs, A., Vanags, A., Gardovskis, J., Strumfa, I. (2019). Molecular classification of diffuse gliomas. Pol. J. Pathol., 70 (4), 246–258.10.5114/pjp.2019.93126
- Johnson, P., Ruffell, B. (2009). CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy-Drug Targets, 8 (3), 208–220.10.2174/187152809788680994
- Kaza, S., Kantheti, L. P., Poosarla, C., Gontu, S. R., Kattappagari, K. K., Baddam, V. R. (2018). A study on the expression of CD44 adhesion molecule in oral squamous cell carcinoma and its correlation with tumor histological grading. J. Orofac. Sci., 10, 42–49.
- Khajuria, N., Metgud, R. (2015). Role of bacteria in oral carcinogenesis. Indian J. Dent., 6 (1), 37–43.10.4103/0975-962X.151709
- Lindquist, D., Ahrlund-Richter, A., Tarjįn, M., Tot, T., Dalianis, T. (2012). Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. Act., 32 (1), 153–161.
- Miletti-González, K. E., Murphy, K., Kumaran, M. N., Ravindranath, A. K., Wernyj, R. P., Kaur, S., Miles, G. D., Lim, E., Chan, R., Chekmareva, M., Heller, D. S., Foran, D., Chen, W., Reiss, M., Bandera, E. V., Kathleen Scotto, K., Rodríguez-Rodríguez, L. (2012). Identification of function for CD44 intracytoplasmic domain (CD44-ICD): Modulation of matrix metalloproteinase (MMP-9) transcription via novel promoter response element. J. Biol. Chem., 287 (23), 18995–19007.10.1074/jbc.M111.318774
- Naga, S. K. S. V., Shekar, P. C., Kattappagari, K. K., Chandra, K. L. P., Reddy, G. S., Reddy, B. V. R. (2019). Expression of cluster differentiation-44 stem cell marker in grades of oral epithelial dysplasia: A preliminary study. J. Oral Maxillofac. Pathol., 23 (2), 203–207.
- Nanci A. (2017). Ten Cate’s Oral Histology: Development, Structure and Function.9th edn. St. Luis, Elsevier. 352 pp.
- Narayan, T. V., Shilpashree, S. (2016). Meta-analysis on clinicopathologic risk factors of leukoplakias undergoing malignant transformation. J. Oral Maxillofac. Pathol.,20 (3), 354–361.
- Negi, L. M., Talegaonkar, S., Jaggi, M., Iqbalz. Z., Khar, R. K. (2012). Role of CD44 in tumour progression and strategies for targeting. J. Drug Target., 20, 561–573.10.3109/1061186X.2012.702767
- Ortiz, R. C., Lopes, N. M., Amor, N. G., José, B. P., Schmerling, C. K., Lara V. S., Moyses, R. A., Rodini, C. O. (2018). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. J. Oral Pathol. Med., 47, 740–747.10.1111/jop.12734
- Pettersen, J. S., Fuentes-Duculan, J., Suįrez-Farińas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., Belkin, D. A., Wang, C. Q. F., Bhuvanendran, S., Johnson-Huang, L. M., Bluth, M. J., Krueger, J. G., Lowes, M. A., Carucci, J. A. (2011). Tumor-associated macrophages in the cutaneous SCC micro-environment are heterogeneously activated. J. Invest. Dermat., 131 (6),1322–1330.10.1038/jid.2011.9
- Pisterna, G. V., Siragusa, M. (2007). CD44 presence in inflamed pulp tissue. J. Endod., 33 (10), 1203–1207.10.1016/j.joen.2007.05.022
- Puré, E., Oaff, C. A. (2001). A crucial role for CD44 in inflammation. Trends Mol. Med., 7 (5), 213–221.10.1016/S1471-4914(01)01963-3
- Reid, P., Marcu, L. G., Olve, I., Moghaddasi, L., Staudacher, A. H., Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiother. Oncol.,135, 1–12.10.1016/j.radonc.2019.02.016
- Renaud-Vilmer, C., Cavelier-Balloy, B. (2017). Precancerous lesions of the buccal epithelium. Ann. Dermatol. Venereol., 144 (2), 100–108.10.1016/j.annder.2016.07.017
- Roye, D. G., Myers, R. B., Brown, D., Poczatek, D. R., Beenken S. W., Grizzle, W. E. (1996). CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int. J. Cancer, 69, 254–258.10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-W
- Speight, P. M., Khurram, S. A., Kujan, O. (2018). Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 125 (6), 612–627.10.1016/j.oooo.2017.12.011
- Sundberg, J., Korytowska, M., Holmberg, E., Bratel, J., Wallström, M., Kjellström, E., Blomgren, J., Kovįcs, A., Öhman, J., Sand, L., Hirsch, J.-M., Giglio, D., Kjeller, G., Bengt Hasséus, B. (2019). Recurrence rates after surgical removal of oral leukoplakia: A prospective longitudinal multi-centre study. PLoS One, 14 (12), e0225682.10.1371/journal.pone.0225682
- Tamatani, T., Takamaru, N., Ohe, G., Akita, K., Nakagawa, T., Miyamoto, Y. (2018). Express of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 instage I and II oral squamous cell carcinoma and their association with clinicopathological factors. Oncol. Lett., 16 (1),1133–1140.
- Wang, S. J., Wong, G, de Heer G. A. M., Xia W, Bourguignon, L.Y. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. The Laryngoscope, 119 (8), 1518–1530.10.1002/lary.20506
- Warnakulasuriya S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral. Oncol., 45 (4–5), 309–316.10.1016/j.oraloncology.2008.06.002
- Wielenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., Berg, F. M., Punta, H., Herrlich, P., Steven T. Pals, S. T. (1993). Advances in brief expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53, 4754–4756.